SIGN IN
Senior Scientist - Protein Engineering jobs in United States
cer-icon
Apply on Employer Site
company-logo

Illumina · 22 hours ago

Senior Scientist - Protein Engineering

Illumina is a company dedicated to expanding access to genomic technology for health equity. They are seeking a Senior Scientist in Protein Engineering to develop novel protein reagents for Next Generation Sequencing (NGS) and to analyze research in protein engineering applied to genomics.
BiotechnologyGeneticsHealth CareMedical
badNo H1Bnote

Responsibilities

Plan, execute and analyze various laboratory experiments to engineer and/or characterize novel enzymes for NGS, with defined goals and timeframes
Participate in multi disciplinarily protein engineering projects and interact with engineers, chemists, and protein scientists, to deliver protein variants with desired properties

Qualification

Protein engineeringDirected evolutionNucleic acid binding proteinsAssay designGenomics technologiesComputational protein designCommunication skills

Required

5+ years of hands-on experience in protein engineering and directed evolution
Experience in the expression, purification and biochemical characterization of nucleic acid binding proteins (e.g. DNA repair proteins, ligases, polymerases, recombinases, etc.) is also an advantage
Assay design experience is an advantage
Sound understanding of the latest genomics technologies and methodologies
Experience with computation protein design and/or ML/AI-assisted protein engineering
Good communication skills
Typically requires a minimum of 5 years of related experience with a Bachelor's degree in protein engineering or biochemistry; or 3 years and a Master's degree in protein engineering or biochemistry; or a PhD in protein engineering or biochemistry without experience; or equivalent work experience in protein engineering or biochemistry

Benefits

Access to genomics sequencing
Family planning
Health/dental/vision
Retirement benefits
Paid time off

Company

Illumina

company-logo
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

Funding

Current Stage
Public Company
Total Funding
$1.28B
Key Investors
Bank of America
2024-09-06Post Ipo Debt· $500M
2023-01-04Post Ipo Debt· $750M
2000-07-28IPO

Leadership Team

leader-logo
Steven Barnard
Chief Technology Officer, Head of Research & Product Development
linkedin
leader-logo
Jenny Lei Zheng
SVP & GM of Greater China
linkedin
Company data provided by crunchbase